An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Päätekijä: | Bristy, Israt Zerin |
---|---|
Muut tekijät: | Kabir, Md. Tanvir |
Aineistotyyppi: | Opinnäyte |
Kieli: | English |
Julkaistu: |
Brac University
2021
|
Aiheet: | |
Linkit: | http://hdl.handle.net/10361/15619 |
Samankaltaisia teoksia
-
Molecules associated with the development of lung cancer
Tekijä: Rahman, Adree, et al.
Julkaistu: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Tekijä: Shabnam, Musharrat
Julkaistu: (2018) -
Immunotherapy in the Management of Lung Cancer
Tekijä: Tasnim, Humayra
Julkaistu: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Tekijä: Paul, Pulock
Julkaistu: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
Tekijä: Mim, Shanzida
Julkaistu: (2023)